Note: Ingredients listed on restricted chemical lists
EC/CAS
7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
N/A
General Information
Revision date
2015-06-02
Product name
Terramycin; Liquamycin; LA-200, Primamycin
Product Synonyms
TM LA; TMLA; LA-200, Primamycin LA Injectable Solution
Icons in SDS
Company Information
company name
Zoetis Inc
e-mail address of the competent person responsible for the Safety Data Sheet
VMIPSrecords@zoetis.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Appearance: Clear, yellow to amber sterile solution
2.1 Classification of the substance or mixture
Reproductive Toxicity: Category 1A
EU Classification
EU Indication of danger Toxic to reproduction Category 1 EU Symbol: T EU Risk Phrases: R60 - May impair fertility. R61 - May cause harm to the unborn child.
Signal word
Danger
Hazard statements
H360 - May damage fertility or the unborn child
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical attention/advice P405 - Store locked up P501 - Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
Short Term: Exposure to sunlight following contact may result in skin reactions in rare instances. Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on the developing fetus. Known Clinical Effects: Ingestion of this material may cause effects similar to those generally seen in clinical use of antibiotics including gastrointestinal irritation, vomiting, transient diarrhea, nausea, and abdominal pain. Symptoms of chronic exposure to tetracyclines include redness and swelling of the skin, rash, chills, tooth discoloration, yellowing of the skin and eyes, nausea, vomiting, diarrhea, stomach pain, and chest pain. Clinical use of this drug has caused liver effects kidney dysfunction. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
